◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
安旭生物 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
+Revenue 541.0M 503.0M 6.2B 1.6B 1.2B
Revenue Growth % 7.6% -91.8% 288.0% 32.4% --
Total Revenue 541.0M 503.0M 6.2B 1.6B 1.2B
Cost Of Revenue 329.0M 290.0M 1.6B 549.0M 289.0M
+Gross Profit 212.0M 213.0M 4.6B 1.0B 911.0M
Gross Margin % 39.2% 42.3% 74.8% 65.4% 75.9%
Total Operating Cost 527.0M 466.0M 2.7B 738.0M 443.0M
Selling Expenses 49.3M 42.8M 494.0M 30.8M 22.7M
Admin Expenses 54.1M 66.5M 74.7M 27.2M 18.1M
Rd Expenses 101.0M 105.0M 329.0M 70.4M 58.4M
Finance Expenses -38.4M -70.9M -534.0M 23.1M 33.4M
+Operating Income 208.0M 167.0M 3.5B 865.0M 762.0M
Operating Margin % 38.4% 33.2% 57.2% 54.4% 63.5%
Non Operating Income 3.5M 165,200 891,400 11,500 10,000
Non Operating Expenses 468,400 23.8M 10.2M 465,000 392,600
Investment Income 118.0M 140.0M 58.4M 11.8M 1.3M
Fair Value Change Income 63.4M -54.8M -9.4M 101,500 --
Asset Disposal Income 4.6M 7.2M -- 55,000 --
Asset Impairment Loss 12.8M 24.0M 764.0M 11.2M 2.5M
Other Income 8.1M 38.1M 32.3M 2.1M 3.6M
Income Before Tax 211.0M 144.0M 3.5B 865.0M 761.0M
Income Tax 18.4M 2.9M 475.0M 126.0M 112.0M
+Net Income 192.0M 141.0M 3.0B 739.0M 649.0M
Net Margin % 35.5% 28.0% 49.4% 46.5% 54.1%
Net Income Attributable 192.0M 142.0M 3.0B 739.0M 649.0M
Minority Interest -58,300 -588,900 -501,700 -- --
Eps Basic 1.51 1.11 23.95 10.55 14.11
Eps Diluted 1.51 1.11 23.95 10.55 14.11
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash And Equivalents 468.0M 337.0M 2.1B 2.0B 613.0M
Trading Financial Assets 1.5B 1.7B 1.4B 144,900 --
Accounts Receivable 204.0M 196.0M 240.0M 514.0M 250.0M
Notes And Accounts Receivable 204.0M 196.0M 240.0M 514.0M 250.0M
Prepayments 20.1M 62.7M 99.8M 24.6M 7.6M
Inventory 147.0M 197.0M 197.0M 243.0M 126.0M
Total Current Assets 4.8B 4.8B 6.2B 3.0B 1.0B
Fixed Assets -- 646.0M 340.0M 139.0M 71.1M
Fixed Assets Total 625.0M 646.0M 340.0M 139.0M 71.1M
Construction In Progress -- 47.1M 91.4M 53.7M 4.3M
Construction In Progress Total 125.0M 47.1M 91.4M 53.7M 4.3M
Intangible Assets 45.8M 54.7M 41.6M 22.2M 4.5M
Long Term Deferred Expenses 18.1M 19.8M 30.8M 6.3M 2.9M
Total Non Current Assets 999.0M 978.0M 745.0M 301.0M 86.0M
Total Assets 5.8B 5.8B 7.0B 3.3B 1.1B
Short Term Borrowings 280,000 3.0M 2.0M -- --
Accounts Payable 328.0M 373.0M 868.0M 324.0M 168.0M
Advance Receipts -- -- -- -- --
Contract Liabilities 17.8M 13.1M 32.2M 99.5M 11.1M
Total Current Liabilities 475.0M 548.0M 1.4B 657.0M 283.0M
Total Non Current Liabilities 94.2M 136.0M 174.0M 16.6M 5.8M
Total Liabilities 570.0M 684.0M 1.5B 674.0M 289.0M
Paid In Capital 127.0M 127.0M 90.8M 61.3M 46.0M
Capital Reserve 1.1B 1.1B 1.1B 1.1B 75.6M
Surplus Reserve 62.1M 48.6M 46.1M 31.4M 23.7M
Retained Earnings 4.0B 3.9B 4.2B 1.4B 668.0M
Minority Equity -3.8M -3.8M -3.2M -- --
Equity Attributable 5.2B 5.1B 5.4B 2.6B 812.0M
Total Equity 5.2B 5.1B 5.4B 2.6B 812.0M
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash From Sales 530.0M 625.0M 6.6B 1.4B 1.0B
Tax Refunds Received 61.3M 60.6M 265.0M 57.3M 23.9M
Total Operating Cash Inflow 622.0M 740.0M 6.9B 1.4B 1.1B
Cash Paid For Goods 325.0M 516.0M 2.1B 514.0M 261.0M
Cash Paid To Employees 108.0M 190.0M 141.0M 80.5M 46.5M
Taxes Paid 21.6M 183.0M 627.0M 92.1M 48.0M
Total Operating Cash Outflow 547.0M 1.4B 3.2B 769.0M 456.0M
Operating Cash Flow 75.1M -623.0M 3.7B 676.0M 602.0M
Total Investing Cash Inflow 7.9B 6.6B 6.8B 74.1M 300.0M
Total Investing Cash Outflow 7.7B 7.4B 10.4B 372.0M 338.0M
Investing Cash Flow 167.0M -779.0M -3.6B -298.0M -37.8M
Cash From Borrowings -- 1.0M -- -- --
Dividends And Interest Paid 102.0M 455.0M 238.0M -- --
Debt Repayments 2.7M -- -- -- --
Total Financing Cash Inflow -- 1.0M -- 1.1B --
Total Financing Cash Outflow 110.0M 460.0M 253.0M 27.7M 6.1M
Financing Cash Flow -110.0M -459.0M -253.0M 1.1B -6.1M
Net Change In Cash 150.0M -1.8B 90.9M 1.4B 550.0M
Ending Cash Balance 458.0M 308.0M 2.1B 2.0B 613.0M
Capex 107.0M 337.0M 627.0M 200.0M 40.1M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...